Yan‐Bin Ma

608 total citations
34 papers, 469 citations indexed

About

Yan‐Bin Ma is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Yan‐Bin Ma has authored 34 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Yan‐Bin Ma's work include Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (6 papers) and RNA Interference and Gene Delivery (4 papers). Yan‐Bin Ma is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (6 papers) and RNA Interference and Gene Delivery (4 papers). Yan‐Bin Ma collaborates with scholars based in China. Yan‐Bin Ma's co-authors include Sheng‐Hua Chu, Dong‐Fu Feng, Pucha Jiang, Zhiqiang Li, Zhiqiang Li, Biao Yang, Jianhua Qiu, Shuang Liang, Zhiqiang Li and Hong Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, BioMed Research International and International Journal of Nanomedicine.

In The Last Decade

Yan‐Bin Ma

33 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan‐Bin Ma China 13 274 117 73 57 52 34 469
Zhenyan Li China 14 200 0.7× 64 0.5× 47 0.6× 46 0.8× 36 0.7× 54 483
Gwan-Shik Kim South Korea 10 342 1.2× 111 0.9× 130 1.8× 58 1.0× 47 0.9× 11 570
Yang Ying China 13 245 0.9× 180 1.5× 87 1.2× 58 1.0× 9 0.2× 43 507
Zhengxiang Yang China 11 296 1.1× 278 2.4× 69 0.9× 11 0.2× 61 1.2× 13 469
Yongzhao Zhu China 11 187 0.7× 102 0.9× 45 0.6× 23 0.4× 117 2.3× 25 371
Xiaoqin He China 15 245 0.9× 156 1.3× 55 0.8× 24 0.4× 11 0.2× 34 435
S-H Lin Taiwan 11 264 1.0× 94 0.8× 113 1.5× 10 0.2× 10 0.2× 14 567
Jianlong Wang China 11 342 1.2× 231 2.0× 71 1.0× 38 0.7× 15 0.3× 26 531
Da Zhao China 17 336 1.2× 220 1.9× 124 1.7× 23 0.4× 26 0.5× 33 590

Countries citing papers authored by Yan‐Bin Ma

Since Specialization
Citations

This map shows the geographic impact of Yan‐Bin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Bin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Bin Ma more than expected).

Fields of papers citing papers by Yan‐Bin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Bin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Bin Ma. The network helps show where Yan‐Bin Ma may publish in the future.

Co-authorship network of co-authors of Yan‐Bin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Bin Ma. A scholar is included among the top collaborators of Yan‐Bin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Bin Ma. Yan‐Bin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yanyu & Yan‐Bin Ma. (2024). College Students’ Leadership Cultivation: A Case Study of Yango University in China. Journal of Higher Education Theory and Practice. 24(3). 1 indexed citations
2.
Zhang, Wengang, Lu Wang, Luqi Wang, et al.. (2024). Landslide-induced tsunami simulation based on progressive landslide-shallow water equation coupling model: 1946 Aleutian tsunami case. Landslides. 21(7). 1719–1733. 2 indexed citations
3.
Ma, Yan‐Bin, et al.. (2023). A Power Construction Safety Hazard Identification Technology Based on Surveillance Video on Site. Journal of Physics Conference Series. 2592(1). 12089–12089. 1 indexed citations
4.
Ma, Yan‐Bin, et al.. (2020). Characteristics Analysis of Asymmetric Pump-controlled Single-rod Hydraulic Cylinder System. Chinese Hydraulics & Pneumatics. 167. 2 indexed citations
5.
Yang, Biao, Yuan‐Bo Pan, Yan‐Bin Ma, & Sheng‐Hua Chu. (2020). Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas. Frontiers in Oncology. 10. 250–250. 8 indexed citations
6.
Yang, Biao, et al.. (2020). Integrated Transcriptomic Analysis Reveals the Molecular Mechanism of Meningiomas by Weighted Gene Coexpression Network Analysis. BioMed Research International. 2020(1). 4927547–4927547. 1 indexed citations
7.
Yang, Biao, Yan‐Bin Ma, & Sheng‐Hua Chu. (2018). Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells. Cancer Gene Therapy. 25(11-12). 309–316. 14 indexed citations
8.
Chu, Sheng‐Hua, Yan‐Bin Ma, Dong‐Fu Feng, Zhiqiang Li, & Pucha Jiang. (2013). Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy. Journal of Translational Medicine. 11(1). 69–69. 10 indexed citations
9.
Chu, Sheng‐Hua, Yan‐Bin Ma, Dong‐Fu Feng, et al.. (2013). Relationship between SATB1 expression and prognosis in astrocytoma. Journal of Clinical Neuroscience. 20(4). 543–547. 12 indexed citations
10.
Chu, Sheng‐Hua, et al.. (2013). Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1. Molecular Biology Reports. 41(2). 977–986. 17 indexed citations
11.
Chu, Sheng‐Hua, Yan‐Bin Ma, Dong‐Fu Feng, et al.. (2012). Upregulation of SATB1 is associated with the development and progression of glioma. Journal of Translational Medicine. 10(1). 149–149. 46 indexed citations
12.
Chu, Sheng‐Hua, Yan‐Bin Ma, Dong‐Fu Feng, Zhiqiang Li, & Pucha Jiang. (2012). Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme. Molecular Medicine Reports. 7(1). 139–143. 19 indexed citations
13.
Chu, Sheng‐Hua, Dong‐Fu Feng, Yan‐Bin Ma, & Zhiqiang Li. (2012). Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo. International Journal of Nanomedicine. 7. 3659–3659. 63 indexed citations
14.
Chu, Sheng‐Hua, et al.. (2011). Elevated expression of solute carrier family 22 member 18 increases the sensitivity of U251 glioma cells to BCNU. Oncology Letters. 2(6). 1139–1142. 12 indexed citations
15.
Chu, Sheng‐Hua, Yan‐Bin Ma, Dong‐Fu Feng, et al.. (2011). Correlation of low SLC22A18 expression with poor prognosis in patients with glioma. Journal of Clinical Neuroscience. 19(1). 95–98. 35 indexed citations
16.
Chu, Sheng‐Hua, Dong‐Fu Feng, Yan‐Bin Ma, et al.. (2011). Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma. Journal of Translational Medicine. 9(1). 156–156. 34 indexed citations
17.
Chu, Sheng‐Hua, Dong‐Fu Feng, Xueyuan Li, et al.. (2009). c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro. Journal of Neuro-Oncology. 93(2). 183–189. 29 indexed citations
18.
Wang, Hongcai, et al.. (2009). SINUS PERICRANII IN THE RIGHT FRONTAL REGION AND THROMBOSIS. International Journal of Neuroscience. 119(12). 2262–2273. 2 indexed citations
19.
Chu, Sheng‐Hua, et al.. (2008). Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1. Molecular Biology Reports. 36(7). 1967–1975. 31 indexed citations
20.
Chu, Sheng‐Hua, et al.. (2007). c-Met Antisense Oligodeoxynucleotides as a Novel Therapeutic Agent for Glioma: In Vitro and In Vivo Studies of Uptake, Effects, and Toxicity. Journal of Surgical Research. 141(2). 284–288. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026